US20230149023A1 - Spiral delivery system for embolic braid - Google Patents
Spiral delivery system for embolic braid Download PDFInfo
- Publication number
- US20230149023A1 US20230149023A1 US18/093,460 US202318093460A US2023149023A1 US 20230149023 A1 US20230149023 A1 US 20230149023A1 US 202318093460 A US202318093460 A US 202318093460A US 2023149023 A1 US2023149023 A1 US 2023149023A1
- Authority
- US
- United States
- Prior art keywords
- coiled element
- delivery tube
- shape
- affixed
- coiled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04C—BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
- D04C1/00—Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
- D04C1/06—Braid or lace serving particular purposes
- D04C1/08—Tulle fabrics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12095—Threaded connection
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/06—Vascular grafts; stents
Definitions
- This disclosure relates to medical instruments, and more particularly, delivery systems for a device for aneurysm therapy.
- Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues.
- Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow.
- Current alternatives to endovascular or other surgical approaches can include occlusion devices that either fill the sac of the aneurysm with embolic material or treating the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm.
- Naturally formed thrombotic masses formed by treating the entrance of the aneurysm with embolic coils can improve healing compared to aneurysm masses packed with embolic coils by reducing possible distention from arterial walls and permitting reintegration into the original parent vessel shape along the neck plane.
- embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel; at the same time, if the entrance is insufficiently packed, blood flow can persist into the aneurysm.
- Properly implanting embolic coils is therefore challenging, and once implanted, the coils cannot easily be retracted or repositioned.
- embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, because of flow, or even aneurysm size.
- the devices generally can include a delivery tube having a spiral groove on an outer surface of the delivery tube and a braided implant having a spiral segment.
- the spiral segment can engage the spiral groove as the braided implant is delivered to an aneurysm treatment site.
- the braided implant can be implanted, and the delivery tube can be rotated to disengage the spiral segment from the spiral groove. Once released, the spiral segment can reshape to occlude the neck of the aneurysm.
- a system can include a delivery tube and a braided implant.
- the delivery tube can have a lumen, a proximal end, a distal end, and an outer surface with a spiral groove positioned near the distal end.
- the braided implant can have a spiral segment movable from a delivery configuration that engages the spiral groove to a deployed configuration that disengages the spiral groove. A rotation of the delivery tube in relation to the implant can move the spiral segment from the delivery configuration to the deployed configuration.
- the spiral segment and the spiral groove can each have a circular helix shape, and the spiral segment can be positioned in the spiral groove.
- the braided implant can include an outer fold segment attached to the spiral segment that can be positioned over a portion of the outer surface of the delivery tube, a fold that can be positioned distal the distal end of the delivery tube, and an inner fold segment having a substantially tubular structure that can be positioned within the lumen of the delivery tube.
- An inner elongated member can be positioned within the lumen of the delivery tube and can have a proximal end extending proximally from the proximal end of the delivery tube and a distal end positioned within the lumen of the delivery tube detachably attached to an end of the inner fold segment of the braided implant.
- the braided implant can form an occlusive sack having an opening, and the opening can be at least partially obstructed by the spiral segment when in the deployed configuration.
- the opening can have a perimeter and a center. In the deployed configuration, one end of the spiral segment can attach to the occlusive sack near the perimeter while the other end can terminate near the center.
- the outer fold segment and the spiral segment can each have a woven structure with a woven fiber common to both segments.
- the spiral segment can have a non-woven structure.
- An example device for treating an aneurysm can include a tubular delivery member, a braided tubular implant, and a coiled element.
- the tubular delivery member can have a lumen, a distal end, an outer surface, and a helical structure on the outer surface.
- the braided tubular implant can be movable from a delivery configuration having a tubular segment extending proximally within the lumen of the tubular delivery member and an outer fold segment covering a portion of the outer surface of the delivery tube member to an implanted configuration having an occlusive sack with an opening.
- the coiled element can be movable from an engaging configuration that engages the helical structure on the tubular delivery member to an occluding configuration that obstructs at least a portion of the opening of the occlusive sack.
- the coiled element in the engaged configuration, can have a coiled segment in the shape of a circular helix that can engage the helical structure.
- the helical structure can be an indentation in the shape of a circular helix.
- the coiled element can have a coiled segment in the shape of a conical helix or a planar spiral.
- the coiled element can have an affixed portion that can be affixed to the braided implant, and the coiled segment can have an affixed end that can be affixed to the affixed portion and a terminating end.
- the coiled segment can be in a shape having a first circumference measured along the coiled segment from the affixed end through one turn of the conical helix or planar spiral in the direction of the terminating end and a second circumference measured along the coiled segment from the terminating end through one turn of the conical helix or planar spiral in the direction of the affixed end such that the second circumference measures shorter than the first circumference.
- the coiled element can be made of a memory shape metal, and the coiled element can move from a deformed shape in the engaging configuration to a predetermined shape in the occluding configuration.
- An example method for treating an aneurysm can include the steps of providing a braided implant delivery system having a delivery tube and a braided implant, engaging a spiral segment of the braided implant with a spiral groove of the delivery tube, implanting the braided implant in the aneurysm, rotating the delivery tube in relation to the spiral segment to disengage the spiral segment from the spiral groove, and releasing the spiral segment from the delivery tube which releases the braided implant from the delivery tube.
- the step of implanting the braided implant in the aneurysm can include the step of forming an occlusive sack within an aneurysm, the occlusive sack having an opening.
- the method can include the step of occluding at least portion of the neck of the aneurysm with the spiral segment, and the neck can be occluded by obstructing the at least a portion of the opening of the occlusive sack.
- the method can include the step of moving a portion of the spiral segment from a circular helix shape to a conical helix shape.
- the method can include the steps of contacting a wall of the aneurysm with the occlusive sack, and resisting, via the contact between the aneurysm wall and the occlusive sack, a rotation of the occlusive sack in response to the rotating of the delivery tube.
- the step of providing the braided implantation delivery system can include providing a delivery system that additionally includes an inner elongated member, and the method can further comprise the steps of positioning the inner elongated member in a lumen of the delivery tube and attaching the braided implant to the inner elongated member.
- the step of implanting the braided implant in the aneurysm can further include the steps of pushing the inner elongated member distally to invert the braided implant and form an occlusive sack within the aneurysm and detaching the braided implant from the inner elongated member.
- FIG. 1 a illustrates an exploded view of a braided implant and a delivery tube according to the present invention
- FIG. 1 b illustrates a braided implant engaged with a delivery tube according to the present invention
- FIG. 1 c illustrates a cross-sectional view of the braided implant and the delivery tube of FIG. 1 b according to the present invention
- FIG. 2 illustrates a cut-sectional view delivery system according to the present invention
- FIG. 3 illustrates a cut-away of an aneurysm during treatment according to the present invention
- FIGS. 4 a to 4 e illustrate a method of use of a device of the present invention
- FIG. 5 illustrates a cut-away of an aneurysm implanted with a braided implant according to the present invention
- FIG. 6 illustrates a view of a braided implant as viewed at the neck of an aneurysm treated according to the present invention
- FIGS. 7 a to 7 b illustrate a braided implant and a coiled element according to the present invention
- FIG. 8 a illustrates a braided implant and a coiled element according to the present invention
- FIG. 8 b illustrates a view of the braided implant and coiled element of FIG. 8 a as viewed at the neck of an aneurysm treated according to the present invention
- FIGS. 9 to 11 are flow diagrams outlining example method steps for use of a device according to the present invention.
- the delivery system can also serve to occlude the neck of the aneurysm.
- the present disclosure describes various example systems, devices, and methods that can be utilized for at least such purposes.
- FIG. 1 a illustrates an exploded view of a braided implant 300 and a delivery tube 500 .
- the braided implant 300 is shown in a delivery configuration, shaped to be delivered to a treatment site by the delivery tube 500 .
- FIG. 1 b illustrates the braided implant 300 engaged with the delivery tube 500 .
- the assembly illustrated in FIG. 1 b is sized to be inserted into and travel through a microcatheter 600 to a treatment site.
- the microcatheter 600 is shown cut-away in FIG. 1 b , and the delivery system is shown approaching a distal end 614 of the microcatheter 600 .
- FIG. 1 c illustrates a cross-section of the braided implant 300 , delivery tube 500 , and microcatheter as indicated in FIG. 1 b .
- the braided implant 300 can have an inner fold segment 304 shaped to be positioned within a lumen 504 of the delivery tube 500 , a fold 303 that can be positioned distal a distal end 514 of the delivery tube 500 , an outer fold segment 302 that can extend proximally from the fold 303 to cover a portion of an outer surface 508 of the delivery tube 500 , and a spiral segment 350 that can engage a spiral groove 550 on the delivery tube 500 .
- the spiral segment 350 can be elongated with a helical, coiled, or spiral shape.
- the spiral segment 350 can have an attached end 354 attached to the outer fold segment 302 and can extend proximally to a terminating end 352 .
- the spiral segment 350 can include a woven material with a weave that is common to the braided implant 300 such that the weave of the outer fold segment 302 and the weave of the spiral segment 350 share a common fiber.
- the spiral segment 350 can include a non-woven material and can be attached to the braided implant 300 by some other means.
- the spiral segment 350 and the spiral groove 550 can be compatibly dimensioned so that the spiral segment 350 stays in place within the groove as the system is delivered through a catheter 600 to a treatment site.
- the groove can be deep enough for the spiral segment 350 to fit in without falling out.
- the width of the groove can be dimensioned to a fit such that the spiral segment 350 has minimal room to move within the groove.
- FIG. 2 shows a cross-section of a delivery system including a delivery tube 500 , a braided implant 300 , and an inner elongated member 400 .
- the length of the delivery system has been truncated for the purposes of the illustration.
- the delivery system can be sized to be delivered to a treatment site through a catheter or microcatheter 600 .
- the proximal end 412 of the inner elongated member 400 can extend from the proximal end 512 of the delivery tube 500 , which can in turn extend from the proximal end 612 of the delivery catheter 600 .
- the proximal end of the delivery system can be made available to a user to facilitate positioning and implantation of the braided implant 300 at a treatment site.
- the braided implant 300 can include an inner fold segment 304 , extending proximally during delivery and attaching at a first end 312 to the inner elongated member 400 .
- a first end 312 of the braided implant 300 can be detachably attached to the inner elongated member 400 at a distal end 414 by a braid release 404 .
- the inner elongated member 400 can be positioned within the lumen 504 of the delivery tube 500 having a proximal end 412 extending proximal from a proximal end 512 of the delivery tube 500 .
- the braided implant 300 can have a second end 314 .
- the inner fold segment 304 can be enveloped by the delivery tube 500 and held at the first end 312 by the inner elongated member 400 .
- the inner elongated member 400 can be pushed distally, causing the inner fold segment 304 of the braided implant 300 to exit the distal end 514 of the delivery tube 500 .
- the first end 312 of the braided implant 300 can be detached from the inner elongated member 400 at the braid release 404 .
- the braided implant 300 can have a fold 303 distal the distal end 514 of the delivery tube 500 and an outer fold segment 302 extending proximally over an outer surface 508 of the delivery tube 500 to a second end 314 of the braided implant 300 .
- the second end 314 of the braided implant 300 can be attached to a spiral segment 350 that can engage a spiral groove 550 in the outer surface 508 of the delivery tube 500 .
- FIG. 3 illustrates a cut-away of an aneurysm 10 during treatment of a delivery system including a braided implant 300 .
- the braided implant 300 can be delivered through a blood vessel 20 to an opening 16 in the blood vessel wall 22 by a microcatheter 600 .
- the braided implant 300 can invert to form an occlusive sack 308 that can extend to contact the aneurysm wall 14 and fill the aneurysm sac 12 .
- Portions of the braided implant 300 not inverted can be pushed into the occlusive sack 308 by the inner elongated member 400 (shown in FIG. 2 ), forming an embolic filler braid 310 .
- FIG. 3 shows the braided implant 300 partially implanted, such that a portion of the inner fold segment 304 remains in the delivery catheter 600 .
- FIGS. 4 a to 4 e illustrate a method of treating an aneurysm 10 with a braided implant delivery system.
- FIG. 4 a shows the system positioned within a blood vessel 20 at the aneurysm neck 16 .
- FIG. 4 a shows the braided implant 300 in a delivery configuration and the spiral segment 350 in an engaging configuration engaging the spiral groove 550 of delivery tube 500 .
- FIG. 4 b shows an occlusive sack 308 and an embolic filler braid 310 that can be formed by inverting a portion of an inner fold segment 304 of the braided implant 300 and ejecting a non-inverted portion of the inner fold segment 304 respectively.
- FIG. 4 c shows the spiral segment 350 moving distally in response to a rotation of the delivery tube 500 .
- the spiral segment 350 can be sized to easily glide within the spiral groove 550 as the delivery tube 500 is rotated.
- the occlusive sack 308 can contact the aneurysm wall 14 , providing a resistance to prevent the implant 300 from rotating in response to the rotation of the delivery tube 500 .
- the spiral segment 350 can exit the distal end 614 of the microcatheter 600 as it moves distally in response to the rotation.
- the microcatheter 600 can be retracted before rotation of the delivery tube 500 .
- FIG. 4 d shows the spiral segment 350 continuing to move distally in response to continued rotation of the delivery tube 500 . As portions of the spiral segment 350 disengage the spiral groove 550 , the spiral segment 350 can begin to flatten or reshape.
- FIG. 4 e shows the spiral segment 350 disengaged with the delivery tube 500 and reshaped to an occluding configuration.
- the spiral segment 350 can move from a circular helix shape in the engaged configuration to a conical helix shape in the occluding configuration.
- the spiral segment 350 can be otherwise shaped in either the engaging or occluding configuration as will be understood by a person of ordinary skill in the art; for example, the spiral segment 350 can occlude an aneurysm neck with a shape such as a planar spiral.
- Movement of the spiral segment 350 from the engaged configuration to the occluding configuration can be accomplished by various means.
- the spiral segment 350 can be made with a memory shape metal having a predetermined shape and a deformed shape.
- the spiral segment 350 can have a deformed shape in the engaging configuration; a rotation of the delivery tube 500 can cause the spiral segment 350 to contact bodily fluid as the spiral segment 350 exits the microcatheter 600 ; and the spiral segment 350 can move to the predetermined shape in response to contacting the bodily fluids, the spiral segment 350 having the predetermined shape in the occluding configuration.
- the spiral segment 350 can be made with an elastically deformable material.
- the spiral segment 350 can have a stretched shape in the engaging configuration and can be sized to fit within a spiral groove 550 on an outer surface 508 of the delivery tube 500 ; a rotation of the delivery tube 500 can cause the spiral segment 350 to glide off of the distal end 514 of the delivery tube 500 ; and the spiral segment 350 , now uninhibited by the delivery tube 500 , can return to its original shape, the spiral segment 350 having the original shape in the occluding configuration.
- FIG. 5 shows a cut-away view of an aneurysm 10 implanted with a braided implant 300 .
- the braided implant 300 can form an occlusive sack 308 that can extend to the aneurysm wall 14 , and the occlusive sack 308 can be filled with an embolic braid 310 .
- the occlusive sack 308 and the embolic braid 310 can pack the aneurysm 10 to create a thrombotic mass, thereby providing one method of treatment to the aneurysm 10 .
- the occlusive sack 308 can at least partially occlude the neck 16 of the aneurysm 10 reducing blood flow across the entrance to the aneurysm 10 and thereby providing a second method of treatment to the aneurysm 10 .
- the occlusive sack 308 can have an opening 309 positioned in the aneurysm neck 16 . Blood flow across the entrance of the aneurysm 10 can be further inhibited by obstructing the opening 309 .
- the spiral segment 350 can obstruct at least a portion of the opening 309 , thereby occluding at least a portion of the neck 16 of the aneurysm 10 .
- FIG. 6 depicts braided implant 300 having a spiral segment 350 implanted into an aneurysm 10 as viewed from within a blood vessel 20 .
- the blood vessel wall 22 surrounds the aneurysm neck 16
- the occlusive sack 308 is shown occluding the aneurysm neck 16 around the perimeter of the aneurysm neck 16 .
- the occlusive sack 308 is shown having an opening 309 with a perimeter 319 that is measured from the attached end 354 of the spiral segment 350 , around the perimeter 319 of the opening 309 one turn.
- the spiral segment 350 is shown spiraling counterclockwise inward from the attached end 354 to a terminating end 352 .
- the spiral segment 350 can have an outer circumference 358 measured starting from the attached end 354 counterclockwise in the direction of the terminating end 352 through one turn, and an inner circumference 356 measured starting from the terminating end 352 clockwise in the direction of the attached end 354 through one turn. Because the spiral segment 350 spirals inward from the attached end 354 , the outer circumference 358 measures greater than the inner circumference 356 . As shown, the terminating end 352 can be positioned near a center 329 of the occlusive sack opening 309 .
- FIGS. 7 a to 7 b illustrate a braided implant 300 and a coiled element 200 .
- the coiled element 200 can include an affixed portion 210 that is affixed to an end 314 of the outer fold segment 302 of the braided implant 300 and a coiled segment 220 extending from the affixed end 224 of the affixed portion 210 to a terminating end 222 over inner fold segment 304 .
- the affixed portion 210 can be circular, having a circumference sized to fit over an outer surface of a delivery tube (not shown), and the coiled segment 220 can have a helical shape sized to engage a helical structure on the outside of a delivery tube (not shown).
- FIGS. 7 a and 7 b show the braided implant 300 in a delivery configuration and the coiled element 200 in an engaged configuration, each configured to be delivered by a delivery tube 500 through a catheter 600 to a treatment site.
- FIG. 8 a shows a braided implant 300 in a deployed configuration and a coiled element 200 in an occluding configuration.
- the braided implant 300 can invert to form an occlusive sack 308 , and the coiled segment 220 can move to obstruct an opening 309 in the occlusive sack 308 .
- the occlusive sack 308 and the affixed portion 210 of the coiled element 200 can be joined at the opening 309 of the occlusive sack 308 , and the affixed end 224 can be positioned at the perimeter of the opening 309 .
- the braided implant 300 can collapse to form a conical helix, a flattened spiral, or some other shape to obstruct the opening 309 of the occlusive sack 308 .
- FIG. 8 b depicts a braided implant 300 and a coiled element 200 implanted into an aneurysm 10 as viewed from within a blood vessel 20 . From this perspective, the blood vessel wall 22 surrounds the aneurysm neck 16 .
- the implant 300 as shown, can include an occlusive sack 308 , and the coiled element can be in an occluding configuration, for example as shown in FIG. 8 a .
- the occlusive sack 308 can occlude a portion of the aneurysm neck 16 .
- FIG. 8 b shows the occlusive sack 308 occluding a portion of the aneurysm neck 16 around a perimeter of the aneurysm neck 16 .
- the affixed portion 210 of the coiled element 200 can define an opening 309 of the occlusive sack 308 that is not occluded by the occlusive sack 308 .
- the coiled element can have a coiled structure that obstructs the opening 309 of the occlusive sack 308 thereby occluding a portion of the neck 16 of the aneurysm 10 .
- the coiled segment 220 can rotate clockwise (as shown) or counterclockwise.
- the coiled segment 220 can have an outer circumference 228 measured starting at the affixed end 224 affixed to the affixed portion 210 of the coiled element in the direction of the terminating end 222 through one turn and an inner circumference 226 measured starting at the terminating end 222 through one turn in the direction of the affixed end 224 .
- the terminating end 222 can be positioned near the center 329 of the opening 309 of the occlusive sack 308 , and the affixed end 224 can be positioned at the perimeter of the opening 309 . So oriented, the outer circumference 228 can measure greater than the inner circumference 226 .
- FIGS. 9 to 11 are flow diagrams outlining example method steps for use of a device or system for treating an aneurysm 10 .
- the method steps can be implemented by any of the example means described herein or by any means that would be known to one of ordinary skill in the art.
- a braided implant delivery system having a delivery tube and a braided implant can be provided.
- the braided implant can have a spiral segment and the delivery tube can have a spiral groove.
- the braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art.
- the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube.
- the braided implant can be implanted in the aneurysm.
- the delivery tube can be rotated in relation to the spiral segment to disengage the spiral segment from the spiral groove.
- the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube.
- a braided implant delivery system having a braided implant and a delivery tube can be provided.
- the braided implant can have a spiral segment and the delivery tube can have a spiral groove.
- the braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art.
- the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube.
- the braided implant can be implanted in the aneurysm by forming an occlusive sack having an opening within the aneurysm.
- the occlusive sack can contact a wall of the aneurysm.
- the delivery tube can be rotated in relation to the spiral segment to disengage the spiral segment from the spiral groove.
- a contact between the aneurysm wall and the occlusive sack can resist a rotation of the occlusive sack in response to the rotation of the delivery tube.
- the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube.
- a portion of the spiral segment can be moved from a circular helix shape to a conical helix or flat spiral shape.
- at least a portion of the neck of the aneurysm can be occluded by obstructing at least a portion of the opening of the occlusive sack with the spiral segment.
- a braided implant delivery system having a braided implant, a delivery tube, and an inner elongated member can be provided.
- the braided implant can have a spiral segment and the delivery tube can have a spiral groove and a lumen.
- the braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art.
- the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube.
- the inner elongated member can be positioned in the lumen of the delivery tube.
- the braided implant can be attached to the inner elongated member.
- the braided implant can be implanted in the aneurysm by pushing the inner elongated member distally, thereby inverting the braided implant and forming an occlusive sack within the aneurysm then detaching the braided implant from the inner elongated member.
- the delivery tube can be rotated in relation to the spiral segment of the braided implant to disengage the spiral segment from the spiral groove.
- the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube.
- the invention contemplates many variations and modifications of a system, device, or method that can be used to treat an aneurysm with a braided implant. Variations can include but are not limited to alternative geometries of elements and components described herein, utilizing any of numerous materials for each component or element (e.g.
- radiopaque materials including radiopaque materials, memory shape metals, etc.
- additional components including components to position the braided implant at a treatment site, extract the braided implant, or eject a portion of the braided implant from the interior of the delivery tube, utilizing additional components to perform functions described herein, or utilizing additional components to perform functions not described herein, for example.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Manufacturing & Machinery (AREA)
- Textile Engineering (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
Abstract
A device for treating an aneurysm with a braided implant can include a delivery tube having a spiral groove on an outer surface of the delivery tube and a braided implant having a spiral segment. The spiral segment can engage the spiral groove as the braided implant is delivered to an aneurysm treatment site. At the treatment site, the braided implant can be implanted, and the delivery tube can be rotated to disengage the spiral segment from the spiral groove. Once released, the spiral segment can reshape to occlude the neck of the aneurysm.
Description
- This application is a Continuation of U.S. Pat. Application No. 17/128,338 filed Dec. 21, 2020, which is a Continuation of U.S. Pat. Application No. 16/054,055 filed on Aug. 3, 2018, now issued as U.S. Pat. No. 10,905,431, which are incorporated herein by reference in their entirety.
- This disclosure relates to medical instruments, and more particularly, delivery systems for a device for aneurysm therapy.
- Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues. Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. Current alternatives to endovascular or other surgical approaches can include occlusion devices that either fill the sac of the aneurysm with embolic material or treating the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm. When treating the aneurysm neck, blood flow into the entrance of the aneurysm is inhibited, inducing venous stasis in the aneurysm and facilitating a natural formation of a thrombotic mass within the aneurysm.
- Current occlusion devices typically utilize multiple embolic coils to either fill the sac or treat the entrance. In either treatment, obtaining an embolic coil packing density sufficient to either occlude the aneurysm neck or fill the aneurysm sac is difficult and time consuming. Further, aneurysm morphology (e.g. wide neck, bifurcation, etc.) can required ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density.
- Naturally formed thrombotic masses formed by treating the entrance of the aneurysm with embolic coils can improve healing compared to aneurysm masses packed with embolic coils by reducing possible distention from arterial walls and permitting reintegration into the original parent vessel shape along the neck plane. However, embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel; at the same time, if the entrance is insufficiently packed, blood flow can persist into the aneurysm. Properly implanting embolic coils is therefore challenging, and once implanted, the coils cannot easily be retracted or repositioned.
- Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, because of flow, or even aneurysm size.
- An example alternative occlusion device is described in U.S. Pat. No. 8,998,947. However, this approach relies upon the use of embolic coils or mimics the coil approach and therefore suffers many of the limitations of embolic coil approaches such as difficulty achieving a safe packing density and inability to reposition once implanted.
- It is therefore desirable to have a device which easily, accurately, and safely occludes a neck of an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel.
- Disclosed herein are various exemplary devices and systems of the present invention that can address the above needs. The devices generally can include a delivery tube having a spiral groove on an outer surface of the delivery tube and a braided implant having a spiral segment. The spiral segment can engage the spiral groove as the braided implant is delivered to an aneurysm treatment site. At the treatment site, the braided implant can be implanted, and the delivery tube can be rotated to disengage the spiral segment from the spiral groove. Once released, the spiral segment can reshape to occlude the neck of the aneurysm.
- In one example, a system can include a delivery tube and a braided implant. The delivery tube can have a lumen, a proximal end, a distal end, and an outer surface with a spiral groove positioned near the distal end. The braided implant can have a spiral segment movable from a delivery configuration that engages the spiral groove to a deployed configuration that disengages the spiral groove. A rotation of the delivery tube in relation to the implant can move the spiral segment from the delivery configuration to the deployed configuration.
- In the delivery configuration, the spiral segment and the spiral groove can each have a circular helix shape, and the spiral segment can be positioned in the spiral groove.
- The braided implant can include an outer fold segment attached to the spiral segment that can be positioned over a portion of the outer surface of the delivery tube, a fold that can be positioned distal the distal end of the delivery tube, and an inner fold segment having a substantially tubular structure that can be positioned within the lumen of the delivery tube.
- An inner elongated member can be positioned within the lumen of the delivery tube and can have a proximal end extending proximally from the proximal end of the delivery tube and a distal end positioned within the lumen of the delivery tube detachably attached to an end of the inner fold segment of the braided implant.
- The braided implant can form an occlusive sack having an opening, and the opening can be at least partially obstructed by the spiral segment when in the deployed configuration. The opening can have a perimeter and a center. In the deployed configuration, one end of the spiral segment can attach to the occlusive sack near the perimeter while the other end can terminate near the center.
- The outer fold segment and the spiral segment can each have a woven structure with a woven fiber common to both segments. Alternatively, the spiral segment can have a non-woven structure.
- An example device for treating an aneurysm can include a tubular delivery member, a braided tubular implant, and a coiled element. The tubular delivery member can have a lumen, a distal end, an outer surface, and a helical structure on the outer surface. The braided tubular implant can be movable from a delivery configuration having a tubular segment extending proximally within the lumen of the tubular delivery member and an outer fold segment covering a portion of the outer surface of the delivery tube member to an implanted configuration having an occlusive sack with an opening. The coiled element can be movable from an engaging configuration that engages the helical structure on the tubular delivery member to an occluding configuration that obstructs at least a portion of the opening of the occlusive sack.
- In the engaged configuration, the coiled element can have a coiled segment in the shape of a circular helix that can engage the helical structure. The helical structure can be an indentation in the shape of a circular helix.
- In the occluding configuration, the coiled element can have a coiled segment in the shape of a conical helix or a planar spiral. The coiled element can have an affixed portion that can be affixed to the braided implant, and the coiled segment can have an affixed end that can be affixed to the affixed portion and a terminating end. The coiled segment can be in a shape having a first circumference measured along the coiled segment from the affixed end through one turn of the conical helix or planar spiral in the direction of the terminating end and a second circumference measured along the coiled segment from the terminating end through one turn of the conical helix or planar spiral in the direction of the affixed end such that the second circumference measures shorter than the first circumference.
- The coiled element can be made of a memory shape metal, and the coiled element can move from a deformed shape in the engaging configuration to a predetermined shape in the occluding configuration.
- An example method for treating an aneurysm can include the steps of providing a braided implant delivery system having a delivery tube and a braided implant, engaging a spiral segment of the braided implant with a spiral groove of the delivery tube, implanting the braided implant in the aneurysm, rotating the delivery tube in relation to the spiral segment to disengage the spiral segment from the spiral groove, and releasing the spiral segment from the delivery tube which releases the braided implant from the delivery tube.
- The step of implanting the braided implant in the aneurysm can include the step of forming an occlusive sack within an aneurysm, the occlusive sack having an opening.
- The method can include the step of occluding at least portion of the neck of the aneurysm with the spiral segment, and the neck can be occluded by obstructing the at least a portion of the opening of the occlusive sack.
- The method can include the step of moving a portion of the spiral segment from a circular helix shape to a conical helix shape.
- The method can include the steps of contacting a wall of the aneurysm with the occlusive sack, and resisting, via the contact between the aneurysm wall and the occlusive sack, a rotation of the occlusive sack in response to the rotating of the delivery tube.
- The step of providing the braided implantation delivery system can include providing a delivery system that additionally includes an inner elongated member, and the method can further comprise the steps of positioning the inner elongated member in a lumen of the delivery tube and attaching the braided implant to the inner elongated member. The step of implanting the braided implant in the aneurysm can further include the steps of pushing the inner elongated member distally to invert the braided implant and form an occlusive sack within the aneurysm and detaching the braided implant from the inner elongated member.
- The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
-
FIG. 1 a illustrates an exploded view of a braided implant and a delivery tube according to the present invention; -
FIG. 1 b illustrates a braided implant engaged with a delivery tube according to the present invention; -
FIG. 1 c illustrates a cross-sectional view of the braided implant and the delivery tube ofFIG. 1 b according to the present invention; -
FIG. 2 illustrates a cut-sectional view delivery system according to the present invention; -
FIG. 3 illustrates a cut-away of an aneurysm during treatment according to the present invention; -
FIGS. 4 a to 4 e illustrate a method of use of a device of the present invention; -
FIG. 5 illustrates a cut-away of an aneurysm implanted with a braided implant according to the present invention; -
FIG. 6 illustrates a view of a braided implant as viewed at the neck of an aneurysm treated according to the present invention; -
FIGS. 7 a to 7 b illustrate a braided implant and a coiled element according to the present invention; -
FIG. 8 a illustrates a braided implant and a coiled element according to the present invention; -
FIG. 8 b illustrates a view of the braided implant and coiled element ofFIG. 8 a as viewed at the neck of an aneurysm treated according to the present invention; and -
FIGS. 9 to 11 are flow diagrams outlining example method steps for use of a device according to the present invention. - Previous approaches utilizing embolic coils can be improved upon by treating the aneurysm entrance and/or packing the aneurysm with an embolic braided implant. For example, see U.S. Pat. Application No. 15/903,860, incorporated herein, in its entirety, by reference. Treating the aneurysm with the braided implant can have potential advantages over treatments utilizing embolic coils such as a higher packing density, ability to retract and reposition the implant during the implantation procedure, ability to be implanted without ancillary devices such as stents or balloons, reduced risk of recanalizing or compacting, and improved coverage across the aneurysm neck, for example.
- In braided implant delivery systems, it can be advantageous to maintain an attachment between the implant and the delivery system until the implant is in place at the treatment site, then detach the implant so that the delivery system can be extracted. When implanted in an aneurysm, for example, the delivery system can also serve to occlude the neck of the aneurysm. The present disclosure describes various example systems, devices, and methods that can be utilized for at least such purposes.
-
FIG. 1 a illustrates an exploded view of abraided implant 300 and adelivery tube 500. Thebraided implant 300 is shown in a delivery configuration, shaped to be delivered to a treatment site by thedelivery tube 500.FIG. 1 b illustrates thebraided implant 300 engaged with thedelivery tube 500. The assembly illustrated inFIG. 1 b is sized to be inserted into and travel through amicrocatheter 600 to a treatment site. Themicrocatheter 600 is shown cut-away inFIG. 1 b , and the delivery system is shown approaching adistal end 614 of themicrocatheter 600.FIG. 1 c illustrates a cross-section of thebraided implant 300,delivery tube 500, and microcatheter as indicated inFIG. 1 b . - Referring to
FIGS. 1 a to 1 c collectively, thebraided implant 300 can have aninner fold segment 304 shaped to be positioned within alumen 504 of thedelivery tube 500, afold 303 that can be positioned distal adistal end 514 of thedelivery tube 500, anouter fold segment 302 that can extend proximally from thefold 303 to cover a portion of anouter surface 508 of thedelivery tube 500, and aspiral segment 350 that can engage aspiral groove 550 on thedelivery tube 500. - The
spiral segment 350 can be elongated with a helical, coiled, or spiral shape. Thespiral segment 350 can have an attachedend 354 attached to theouter fold segment 302 and can extend proximally to a terminatingend 352. Thespiral segment 350 can include a woven material with a weave that is common to thebraided implant 300 such that the weave of theouter fold segment 302 and the weave of thespiral segment 350 share a common fiber. Alternatively, thespiral segment 350 can include a non-woven material and can be attached to thebraided implant 300 by some other means. - The
spiral segment 350 and thespiral groove 550 can be compatibly dimensioned so that thespiral segment 350 stays in place within the groove as the system is delivered through acatheter 600 to a treatment site. The groove can be deep enough for thespiral segment 350 to fit in without falling out. The width of the groove can be dimensioned to a fit such that thespiral segment 350 has minimal room to move within the groove. -
FIG. 2 shows a cross-section of a delivery system including adelivery tube 500, abraided implant 300, and an innerelongated member 400. The length of the delivery system has been truncated for the purposes of the illustration. - The delivery system can be sized to be delivered to a treatment site through a catheter or
microcatheter 600. Theproximal end 412 of the innerelongated member 400 can extend from the proximal end 512 of thedelivery tube 500, which can in turn extend from theproximal end 612 of thedelivery catheter 600. The proximal end of the delivery system can be made available to a user to facilitate positioning and implantation of thebraided implant 300 at a treatment site. - The
braided implant 300 can include aninner fold segment 304, extending proximally during delivery and attaching at afirst end 312 to the innerelongated member 400. Afirst end 312 of thebraided implant 300 can be detachably attached to the innerelongated member 400 at a distal end 414 by abraid release 404. The innerelongated member 400 can be positioned within thelumen 504 of thedelivery tube 500 having aproximal end 412 extending proximal from a proximal end 512 of thedelivery tube 500. Thebraided implant 300 can have asecond end 314. - During delivery, the
inner fold segment 304 can be enveloped by thedelivery tube 500 and held at thefirst end 312 by the innerelongated member 400. Once the delivery system is positioned at a treatment site, the innerelongated member 400 can be pushed distally, causing theinner fold segment 304 of thebraided implant 300 to exit thedistal end 514 of thedelivery tube 500. Thefirst end 312 of thebraided implant 300 can be detached from the innerelongated member 400 at thebraid release 404. - As shown in
FIG. 2 , thebraided implant 300 can have afold 303 distal thedistal end 514 of thedelivery tube 500 and anouter fold segment 302 extending proximally over anouter surface 508 of thedelivery tube 500 to asecond end 314 of thebraided implant 300. Thesecond end 314 of thebraided implant 300 can be attached to aspiral segment 350 that can engage aspiral groove 550 in theouter surface 508 of thedelivery tube 500. -
FIG. 3 illustrates a cut-away of ananeurysm 10 during treatment of a delivery system including abraided implant 300. Thebraided implant 300 can be delivered through ablood vessel 20 to anopening 16 in theblood vessel wall 22 by amicrocatheter 600. As shown, thebraided implant 300 can invert to form anocclusive sack 308 that can extend to contact theaneurysm wall 14 and fill theaneurysm sac 12. Portions of thebraided implant 300 not inverted can be pushed into theocclusive sack 308 by the inner elongated member 400 (shown inFIG. 2 ), forming anembolic filler braid 310.FIG. 3 shows thebraided implant 300 partially implanted, such that a portion of theinner fold segment 304 remains in thedelivery catheter 600. -
FIGS. 4 a to 4 e illustrate a method of treating ananeurysm 10 with a braided implant delivery system.FIG. 4 a shows the system positioned within ablood vessel 20 at theaneurysm neck 16.FIG. 4 a shows thebraided implant 300 in a delivery configuration and thespiral segment 350 in an engaging configuration engaging thespiral groove 550 ofdelivery tube 500. -
FIG. 4 b shows anocclusive sack 308 and anembolic filler braid 310 that can be formed by inverting a portion of aninner fold segment 304 of thebraided implant 300 and ejecting a non-inverted portion of theinner fold segment 304 respectively. -
FIG. 4 c shows thespiral segment 350 moving distally in response to a rotation of thedelivery tube 500. Thespiral segment 350 can be sized to easily glide within thespiral groove 550 as thedelivery tube 500 is rotated. Theocclusive sack 308 can contact theaneurysm wall 14, providing a resistance to prevent theimplant 300 from rotating in response to the rotation of thedelivery tube 500. As shown, thespiral segment 350 can exit thedistal end 614 of themicrocatheter 600 as it moves distally in response to the rotation. Alternatively (not shown), themicrocatheter 600 can be retracted before rotation of thedelivery tube 500. -
FIG. 4 d shows thespiral segment 350 continuing to move distally in response to continued rotation of thedelivery tube 500. As portions of thespiral segment 350 disengage thespiral groove 550, thespiral segment 350 can begin to flatten or reshape. -
FIG. 4 e shows thespiral segment 350 disengaged with thedelivery tube 500 and reshaped to an occluding configuration. As shown, thespiral segment 350 can move from a circular helix shape in the engaged configuration to a conical helix shape in the occluding configuration. Alternatively, thespiral segment 350 can be otherwise shaped in either the engaging or occluding configuration as will be understood by a person of ordinary skill in the art; for example, thespiral segment 350 can occlude an aneurysm neck with a shape such as a planar spiral. - Movement of the
spiral segment 350 from the engaged configuration to the occluding configuration can be accomplished by various means. For example, thespiral segment 350 can be made with a memory shape metal having a predetermined shape and a deformed shape. In such an example, thespiral segment 350 can have a deformed shape in the engaging configuration; a rotation of thedelivery tube 500 can cause thespiral segment 350 to contact bodily fluid as thespiral segment 350 exits themicrocatheter 600; and thespiral segment 350 can move to the predetermined shape in response to contacting the bodily fluids, thespiral segment 350 having the predetermined shape in the occluding configuration. - Alternatively, the
spiral segment 350 can be made with an elastically deformable material. In such an example, thespiral segment 350 can have a stretched shape in the engaging configuration and can be sized to fit within aspiral groove 550 on anouter surface 508 of thedelivery tube 500; a rotation of thedelivery tube 500 can cause thespiral segment 350 to glide off of thedistal end 514 of thedelivery tube 500; and thespiral segment 350, now uninhibited by thedelivery tube 500, can return to its original shape, thespiral segment 350 having the original shape in the occluding configuration. -
FIG. 5 shows a cut-away view of ananeurysm 10 implanted with abraided implant 300. Thebraided implant 300 can form anocclusive sack 308 that can extend to theaneurysm wall 14, and theocclusive sack 308 can be filled with anembolic braid 310. Theocclusive sack 308 and theembolic braid 310 can pack theaneurysm 10 to create a thrombotic mass, thereby providing one method of treatment to theaneurysm 10. As shown, theocclusive sack 308 can at least partially occlude theneck 16 of theaneurysm 10 reducing blood flow across the entrance to theaneurysm 10 and thereby providing a second method of treatment to theaneurysm 10. However, theocclusive sack 308 can have anopening 309 positioned in theaneurysm neck 16. Blood flow across the entrance of theaneurysm 10 can be further inhibited by obstructing theopening 309. As shown inFIG. 5 , thespiral segment 350 can obstruct at least a portion of theopening 309, thereby occluding at least a portion of theneck 16 of theaneurysm 10. -
FIG. 6 depicts braidedimplant 300 having aspiral segment 350 implanted into ananeurysm 10 as viewed from within ablood vessel 20. From this perspective, theblood vessel wall 22 surrounds theaneurysm neck 16, and theocclusive sack 308 is shown occluding theaneurysm neck 16 around the perimeter of theaneurysm neck 16. Theocclusive sack 308 is shown having anopening 309 with aperimeter 319 that is measured from the attachedend 354 of thespiral segment 350, around theperimeter 319 of theopening 309 one turn. Thespiral segment 350 is shown spiraling counterclockwise inward from the attachedend 354 to a terminatingend 352. As shown, thespiral segment 350 can have anouter circumference 358 measured starting from the attachedend 354 counterclockwise in the direction of the terminatingend 352 through one turn, and aninner circumference 356 measured starting from the terminatingend 352 clockwise in the direction of the attachedend 354 through one turn. Because thespiral segment 350 spirals inward from the attachedend 354, theouter circumference 358 measures greater than theinner circumference 356. As shown, the terminatingend 352 can be positioned near acenter 329 of theocclusive sack opening 309. -
FIGS. 7 a to 7 b illustrate abraided implant 300 and acoiled element 200. As shown, thecoiled element 200 can include an affixedportion 210 that is affixed to anend 314 of theouter fold segment 302 of thebraided implant 300 and acoiled segment 220 extending from the affixedend 224 of the affixedportion 210 to a terminatingend 222 overinner fold segment 304. The affixedportion 210 can be circular, having a circumference sized to fit over an outer surface of a delivery tube (not shown), and thecoiled segment 220 can have a helical shape sized to engage a helical structure on the outside of a delivery tube (not shown).FIGS. 7 a and 7 b show thebraided implant 300 in a delivery configuration and thecoiled element 200 in an engaged configuration, each configured to be delivered by adelivery tube 500 through acatheter 600 to a treatment site. -
FIG. 8 a shows abraided implant 300 in a deployed configuration and acoiled element 200 in an occluding configuration. Thebraided implant 300 can invert to form anocclusive sack 308, and thecoiled segment 220 can move to obstruct anopening 309 in theocclusive sack 308. Theocclusive sack 308 and the affixedportion 210 of thecoiled element 200 can be joined at theopening 309 of theocclusive sack 308, and the affixedend 224 can be positioned at the perimeter of theopening 309. Thebraided implant 300 can collapse to form a conical helix, a flattened spiral, or some other shape to obstruct theopening 309 of theocclusive sack 308. -
FIG. 8 b depicts abraided implant 300 and acoiled element 200 implanted into ananeurysm 10 as viewed from within ablood vessel 20. From this perspective, theblood vessel wall 22 surrounds theaneurysm neck 16. Theimplant 300, as shown, can include anocclusive sack 308, and the coiled element can be in an occluding configuration, for example as shown inFIG. 8 a . Theocclusive sack 308 can occlude a portion of theaneurysm neck 16.FIG. 8 b shows theocclusive sack 308 occluding a portion of theaneurysm neck 16 around a perimeter of theaneurysm neck 16. The affixedportion 210 of thecoiled element 200 can define anopening 309 of theocclusive sack 308 that is not occluded by theocclusive sack 308. The coiled element can have a coiled structure that obstructs theopening 309 of theocclusive sack 308 thereby occluding a portion of theneck 16 of theaneurysm 10. - The
coiled segment 220 can rotate clockwise (as shown) or counterclockwise. Thecoiled segment 220 can have anouter circumference 228 measured starting at the affixedend 224 affixed to the affixedportion 210 of the coiled element in the direction of the terminatingend 222 through one turn and aninner circumference 226 measured starting at the terminatingend 222 through one turn in the direction of the affixedend 224. The terminatingend 222 can be positioned near thecenter 329 of theopening 309 of theocclusive sack 308, and the affixedend 224 can be positioned at the perimeter of theopening 309. So oriented, theouter circumference 228 can measure greater than theinner circumference 226. -
FIGS. 9 to 11 are flow diagrams outlining example method steps for use of a device or system for treating ananeurysm 10. The method steps can be implemented by any of the example means described herein or by any means that would be known to one of ordinary skill in the art. - Referring to
method 700 outlined inFIG. 9 , in step 710 a braided implant delivery system having a delivery tube and a braided implant can be provided. The braided implant can have a spiral segment and the delivery tube can have a spiral groove. The braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art. Instep 720 the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube. Instep 730 the braided implant can be implanted in the aneurysm. Instep 740 the delivery tube can be rotated in relation to the spiral segment to disengage the spiral segment from the spiral groove. Instep 750 the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube. - Referring to
method 800 outlined inFIG. 10 , in step 810 a braided implant delivery system having a braided implant and a delivery tube can be provided. The braided implant can have a spiral segment and the delivery tube can have a spiral groove. The braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art. Instep 820 the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube. Instep 830 the braided implant can be implanted in the aneurysm by forming an occlusive sack having an opening within the aneurysm. Instep 835 the occlusive sack can contact a wall of the aneurysm. Instep 840 the delivery tube can be rotated in relation to the spiral segment to disengage the spiral segment from the spiral groove. In step 845 a contact between the aneurysm wall and the occlusive sack can resist a rotation of the occlusive sack in response to the rotation of the delivery tube. Instep 850 the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube. In step 860 a portion of the spiral segment can be moved from a circular helix shape to a conical helix or flat spiral shape. Instep 870 at least a portion of the neck of the aneurysm can be occluded by obstructing at least a portion of the opening of the occlusive sack with the spiral segment. - Referring to
method 900 outlined inFIG. 11 , in step 910 a braided implant delivery system having a braided implant, a delivery tube, and an inner elongated member can be provided. The braided implant can have a spiral segment and the delivery tube can have a spiral groove and a lumen. The braided implant delivery system can be any of the delivery systems described herein having any combination of the features described herein, as well as any features that would be known to one skilled in the art. Instep 920 the spiral segment of the braided implant can be engaged with the spiral groove of the delivery tube. In step 923 the inner elongated member can be positioned in the lumen of the delivery tube. Instep 927 the braided implant can be attached to the inner elongated member. Instep 930 the braided implant can be implanted in the aneurysm by pushing the inner elongated member distally, thereby inverting the braided implant and forming an occlusive sack within the aneurysm then detaching the braided implant from the inner elongated member. Instep 940 the delivery tube can be rotated in relation to the spiral segment of the braided implant to disengage the spiral segment from the spiral groove. Instep 950 the spiral segment can be released from the delivery tube thereby releasing the braided implant from the delivery tube. - The descriptions contained herein are examples of embodiments of the invention and are not intended to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of a system, device, or method that can be used to treat an aneurysm with a braided implant. Variations can include but are not limited to alternative geometries of elements and components described herein, utilizing any of numerous materials for each component or element (e.g. radiopaque materials, memory shape metals, etc.), utilizing additional components including components to position the braided implant at a treatment site, extract the braided implant, or eject a portion of the braided implant from the interior of the delivery tube, utilizing additional components to perform functions described herein, or utilizing additional components to perform functions not described herein, for example. These modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.
Claims (20)
1. A system comprising:
a delivery tube configured to travel through vasculature and comprising a lumen therethrough, a distal end, an outer surface, and a helical structure on the outer surface;
a braided tubular implant movable from a delivery configuration to an implanted configuration,
the delivery configuration comprising a tubular segment extending proximally within the lumen of the tubular delivery member and an outer fold segment covering a portion of the outer surface of the tubular delivery member, and
the implanted configuration comprising an occlusive sack comprising an opening; and
a coiled element movable from an engaging configuration to an occluding configuration upon rotation of the tubular delivery member in relation to the braided tubular implant,
wherein at least a portion of the coiled element is shaped in a circular helix shape and engages the helical structure when the coiled element is in the engaging configuration, and
wherein the portion of the coiled element shaped in the circular helix shape obstructs at least a portion of the opening of the occlusive sack when the coiled element is in the occluding configuration by forming a conical helix or a planar spiral.
2. The system of claim 1 , wherein the helical structure is an indentation in the shape of a circular helix.
3. The system of claim 1 ,
wherein the coiled element comprises a memory shape metal, and
wherein the memory shape metal is configured to move from a deformed shape when the coiled element is engaged with the helical structure to a predetermined shape upon disengaging from the helical structure.
4. The system of claim 1 ,
wherein the coiled element comprises an affixed portion affixed to the braided implant, and wherein the coiled element further comprises:
an affixed end affixed to the affixed portion of the coiled element;
a terminating end;
a first circumference measured along the coiled element from the affixed end through one turn of the conical helix in the direction of the terminating end; and
a second circumference measured along the coiled element from the terminating end through one turn of the conical helix in the direction of the affixed end, the second circumference measuring shorter than the first circumference.
5. The system of claim 4 , wherein the affixed portion is circular and has a circumference sized to fit over the outer surface of the delivery tube, and the coiled segment has a helical shape sized to engage the helical structure on the outside of the delivery tube.
6. The system of claim 4 , wherein the braided tubular implant inverts to form the occlusive sack and the coiled segment moves to obstruct the opening in the occlusive sack, and wherein the occlusive sack and the affixed portion of the coiled element are joined at the opening of the occlusive sack.
7. The system of claim 6 , wherein the affixed portion of the coiled element defines the opening of the occlusive sack and the coiled segment obstructs the opening of the occlusive sack.
8. An implantation system comprising:
a delivery tube comprising a lumen therethrough, a distal end, an outer surface, and a helical groove on the outer surface thereon; and
an implant comprising:
a tubular braid movable to an implanted shape comprising an occlusive sack comprising an opening, and
a coiled element extending from the opening of the tubular braid,
wherein a portion of the coiled element shaped in a circular helix shape is positioned within the helical groove,
wherein the coiled element is configured, upon rotation of the delivery tube in relation to the tubular braid, to disengage from the helical groove and thereby disengage the implant from the delivery tube, and
wherein the portion of the coiled element shaped in the circular helix shape is configured to obstruct at least a portion of the opening of the occlusive sack of the tubular braid by forming a conical helix or a planar spiral upon disengaging from the helical groove.
9. The implantation system of claim 8 , wherein the helical structure is an indentation in the shape of a circular helix.
10. The implantation system of claim 8 ,
wherein the coiled element comprises a memory shape metal, and
wherein the memory shape metal is configured to move from a deformed shape when the coiled element is engaged with the helical groove to a predetermined shape upon disengaging from the helical structure.
11. The implantation system of claim 8 ,
wherein the coiled element comprises an affixed portion affixed to the braided implant, and wherein the coiled element further comprises:
an affixed end affixed to the affixed portion of the coiled element;
a terminating end;
a first circumference measured along the coiled element from the affixed end through one turn of the conical helix in the direction of the terminating end; and
a second circumference measured along the coiled element from the terminating end through one turn of the conical helix in the direction of the affixed end, the second circumference measuring shorter than the first circumference.
12. The implantation system of claim 11 , wherein the affixed portion is circular and has a circumference sized to fit over the outer surface of the delivery tube, and the coiled segment has a helical shape sized to engage the helical groove on the outside of the delivery tube.
13. The implantation system of claim 11 , wherein the braided tubular implant inverts to form the occlusive sack and the coiled segment moves to obstruct the opening in the occlusive sack, and wherein the occlusive sack and the affixed portion of the coiled element are joined at the opening of the occlusive sack.
14. The implantation system of claim 13 , wherein the affixed portion of the coiled element defines the opening of the occlusive sack, and the coiled segment obstructs the opening of the occlusive sack.
15. A method comprising:
collapsing a coiled element affixed to a braided implant within a helical groove on a delivery tube so that the coiled element is positioned over an outer surface of the delivery tube and releasable from the delivery tube upon rotation of the delivery tube in relation to the braided implant;
inserting a majority of the braided implant within a lumen of the delivery tube;
configuring the delivery tube and braided implant for delivery through vasculature;
moving the braided implant to an implanted shape comprising an opening from which the affixed portion and coiled element extend; and
disengaging the coiled element from the helical groove, thereby causing the coiled element to form a conical helix shape or planar spiral shape within the opening of the implanted shape and to obstruct the opening of the implanted shape.
16. The method of claim 15 , further comprising:
shaping the coiled element such that the coiled element forms a conical helix shape or planar spiral shape upon disengaging from the helical groove.
17. The method of claim 15 , further comprising:
forming the coiled element to comprise a memory shape metal configured to move from a deformed shape when the coiled element is positioned within the helical groove to a predetermined shape upon the coiled element disengaging from the helical groove.
18. The method of claim 15 , further comprising:
pushing the majority of the braided implant distally from the lumen of the delivery tube.
19. The method of claim 18 , further comprising:
inverting a tubular portion of the braided implant as the tubular portion is pushed distally from the lumen of the delivery tube.
20. A method for treating an aneurysm, the method comprising:
providing a braided implant delivery system comprising a braided implant comprising a coiled element affixed to the braided implant and a delivery tube comprising a spiral groove;
engaging the coiled element with the spiral groove;
implanting the braided implant in the aneurysm;
rotating the delivery tube in relation to the coiled element of the braided implant to disengage the coiled element from the spiral groove;
releasing the coiled element from the delivery tube which releases the braided implant from the delivery tube;
moving a portion of the coiled element from a circular helix shape to a conical helix shape or planar spiral shape; and
occluding at least portion of the neck of the aneurysm with the coiled element.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/093,460 US20230149023A1 (en) | 2018-08-03 | 2023-01-05 | Spiral delivery system for embolic braid |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/054,055 US10905431B2 (en) | 2018-08-03 | 2018-08-03 | Spiral delivery system for embolic braid |
US17/128,338 US11547414B2 (en) | 2018-08-03 | 2020-12-21 | Spiral delivery system for embolic braid |
US18/093,460 US20230149023A1 (en) | 2018-08-03 | 2023-01-05 | Spiral delivery system for embolic braid |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/128,338 Continuation US11547414B2 (en) | 2018-08-03 | 2020-12-21 | Spiral delivery system for embolic braid |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230149023A1 true US20230149023A1 (en) | 2023-05-18 |
Family
ID=67544043
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/054,055 Active 2039-02-21 US10905431B2 (en) | 2018-08-03 | 2018-08-03 | Spiral delivery system for embolic braid |
US17/128,338 Active 2038-10-21 US11547414B2 (en) | 2018-08-03 | 2020-12-21 | Spiral delivery system for embolic braid |
US18/093,460 Pending US20230149023A1 (en) | 2018-08-03 | 2023-01-05 | Spiral delivery system for embolic braid |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/054,055 Active 2039-02-21 US10905431B2 (en) | 2018-08-03 | 2018-08-03 | Spiral delivery system for embolic braid |
US17/128,338 Active 2038-10-21 US11547414B2 (en) | 2018-08-03 | 2020-12-21 | Spiral delivery system for embolic braid |
Country Status (13)
Country | Link |
---|---|
US (3) | US10905431B2 (en) |
EP (1) | EP3603540A1 (en) |
JP (1) | JP7358109B2 (en) |
KR (1) | KR20200015429A (en) |
CN (1) | CN110786907A (en) |
AU (1) | AU2019210654A1 (en) |
BR (1) | BR102019016092A2 (en) |
CA (1) | CA3050932A1 (en) |
CO (1) | CO2019008501A1 (en) |
IL (1) | IL268442A (en) |
MX (1) | MX2019009239A (en) |
RU (1) | RU2019124547A (en) |
TW (1) | TW202027685A (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
US12004750B2 (en) | 2008-05-01 | 2024-06-11 | Aneuclose Llc | Methods for creating an expandable two-part intrasacular aneurysm occlusion device from a tubular mesh |
US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
US9999413B2 (en) | 2015-01-20 | 2018-06-19 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms and method for use |
EP4120964A4 (en) * | 2020-03-17 | 2024-03-27 | Ka Medical, LLC | Expanding medical device with support |
US11471651B2 (en) * | 2020-06-22 | 2022-10-18 | Medtronic, Inc. | Balloon catheter including a guidewire tube with a friction-increasing outer coating |
CN111938886B (en) * | 2020-08-21 | 2022-09-20 | 深圳市人民医院 | Balloon expanding type support and taking-out device thereof |
CN114098878B (en) * | 2020-08-31 | 2024-02-20 | 微创神通医疗科技(上海)有限公司 | Hemangioma plugging device, hemangioma plugging treatment device and hemangioma plugging system |
CN112656477B (en) * | 2020-12-31 | 2023-06-20 | 杭州德诺脑神经医疗科技有限公司 | Aneurysm occlusion device and microcatheter therefor |
US11134954B1 (en) * | 2021-02-01 | 2021-10-05 | Accumedical Beijing Ltd. | Braided embolization apparatus |
CN113855145B (en) * | 2021-10-29 | 2023-06-30 | 微创神通医疗科技(上海)有限公司 | Hemangioma plugging device, hemangioma plugging treatment device and hemangioma plugging system |
JP7204311B1 (en) | 2022-08-10 | 2023-01-16 | 暢利 原 | Backflow prevention tool |
Family Cites Families (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5797952A (en) * | 1996-06-21 | 1998-08-25 | Localmed, Inc. | System and method for delivering helical stents |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US20050187564A1 (en) * | 1999-12-23 | 2005-08-25 | Swaminathan Jayaraman | Occlusive coil manufacturing and delivery |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US6866679B2 (en) * | 2002-03-12 | 2005-03-15 | Ev3 Inc. | Everting stent and stent delivery system |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
US7331973B2 (en) * | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US7371228B2 (en) | 2003-09-19 | 2008-05-13 | Medtronic Vascular, Inc. | Delivery of therapeutics to treat aneurysms |
US7842069B2 (en) | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
AU2005305367A1 (en) | 2004-09-22 | 2006-05-18 | Lee R. Guterman | Cranial aneurysm treatment arrangement |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US9636115B2 (en) | 2005-06-14 | 2017-05-02 | Stryker Corporation | Vaso-occlusive delivery device with kink resistant, flexible distal end |
US7850685B2 (en) | 2005-06-20 | 2010-12-14 | Medtronic Ablation Frontiers Llc | Ablation catheter |
WO2007006139A1 (en) | 2005-07-12 | 2007-01-18 | Smart Biotech Inc. | Aneurysm occlusion device |
WO2007047851A2 (en) | 2005-10-19 | 2007-04-26 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
AU2006330786B2 (en) | 2005-11-17 | 2012-02-02 | Microvention, Inc. | Three-dimensional complex coil |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
EP1968491B1 (en) | 2005-12-22 | 2010-07-07 | Symetis SA | Stent-valves for valve replacement and associated methods and systems for surgery |
US9757260B2 (en) | 2006-03-30 | 2017-09-12 | Medtronic Vascular, Inc. | Prosthesis with guide lumen |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
BRPI0711784B8 (en) | 2006-06-15 | 2021-06-22 | Microvention Inc | embolization device constructed of expandable polymer and its method of preparation |
US7832773B2 (en) | 2006-09-18 | 2010-11-16 | Krohn Kenneth P | Adjustable connector and method for its use |
WO2008074027A1 (en) * | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
US20110144669A1 (en) * | 2007-09-11 | 2011-06-16 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
WO2009086208A2 (en) | 2007-12-21 | 2009-07-09 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
US8974518B2 (en) | 2008-03-25 | 2015-03-10 | Medtronic Vascular, Inc. | Eversible branch stent-graft and deployment method |
WO2009135075A1 (en) | 2008-04-30 | 2009-11-05 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US9232992B2 (en) | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
CA2758509C (en) | 2009-04-15 | 2018-02-20 | Microvention, Inc. | Implant delivery system |
US8758423B2 (en) | 2009-06-18 | 2014-06-24 | Graftcraft I Goteborg Ab | Device and method for treating ruptured aneurysms |
WO2011038017A1 (en) | 2009-09-22 | 2011-03-31 | Penumbra, Inc. | Manual actuation system for deployment of implant |
CA2795740C (en) | 2010-04-14 | 2018-03-13 | Microvention, Inc. | Implant delivery device |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
US8876878B2 (en) | 2010-07-23 | 2014-11-04 | Medtronic, Inc. | Attachment mechanism for stent release |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US8616040B2 (en) | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
CN103260665B (en) | 2010-12-20 | 2015-08-19 | 微温森公司 | Polymer support and manufacture method thereof |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
US9486604B2 (en) | 2011-05-12 | 2016-11-08 | Medtronic, Inc. | Packaging and preparation tray for a delivery system |
WO2012158668A1 (en) | 2011-05-17 | 2012-11-22 | Stryker Corporation | Method of fabricating an implantable medical device that includes one or more thin film polymer support layers |
WO2012166467A1 (en) | 2011-05-27 | 2012-12-06 | Stryker Corporation | Assembly for percutaneously inserting an implantable medical device, steering the device to a target location and deploying the device |
US9750565B2 (en) | 2011-09-30 | 2017-09-05 | Medtronic Advanced Energy Llc | Electrosurgical balloons |
WO2013138789A1 (en) | 2012-03-16 | 2013-09-19 | Microvention, Inc. | Stent and stent delivery device |
US9717421B2 (en) | 2012-03-26 | 2017-08-01 | Medtronic, Inc. | Implantable medical device delivery catheter with tether |
US9833625B2 (en) | 2012-03-26 | 2017-12-05 | Medtronic, Inc. | Implantable medical device delivery with inner and outer sheaths |
US9242290B2 (en) | 2012-04-03 | 2016-01-26 | Medtronic Vascular, Inc. | Method and apparatus for creating formed elements used to make wound stents |
US9700399B2 (en) | 2012-04-26 | 2017-07-11 | Medtronic Vascular, Inc. | Stopper to prevent graft material slippage in a closed web stent-graft |
US9549832B2 (en) | 2012-04-26 | 2017-01-24 | Medtronic Vascular, Inc. | Apparatus and methods for filling a drug eluting medical device via capillary action |
US9149190B2 (en) | 2012-07-17 | 2015-10-06 | Stryker Corporation | Notification system of deviation from predefined conditions |
US9770251B2 (en) | 2012-08-13 | 2017-09-26 | Microvention, Inc. | Shaped removal device |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
CN104717983B (en) | 2012-10-15 | 2018-09-18 | 微仙美国有限公司 | It polymerize therapeutic combination |
KR102309795B1 (en) | 2012-11-13 | 2021-10-08 | 코비디엔 엘피 | Occlusive devices |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
WO2014089390A1 (en) | 2012-12-07 | 2014-06-12 | Medtronic, Inc. | Minimally invasive implantable neurostimulation system |
US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
US9585741B2 (en) | 2013-02-22 | 2017-03-07 | NeuroVasc Technologies, Inc | Embolus removal device with blood flow restriction and related methods |
US9539382B2 (en) | 2013-03-12 | 2017-01-10 | Medtronic, Inc. | Stepped catheters with flow restrictors and infusion systems using the same |
WO2014150824A1 (en) | 2013-03-14 | 2014-09-25 | Stryker Corporation | Vaso-occlusive device delivery system |
EP3009084B1 (en) | 2013-03-14 | 2017-09-13 | Stryker Corporation | Vaso-occlusive device delivery system |
US9539011B2 (en) | 2013-03-14 | 2017-01-10 | Stryker Corporation | Vaso-occlusive device delivery system |
US9833252B2 (en) | 2013-03-15 | 2017-12-05 | Microvention, Inc. | Multi-component obstruction removal system and method |
US9398966B2 (en) | 2013-03-15 | 2016-07-26 | Medtronic Vascular, Inc. | Welded stent and stent delivery system |
CN105377184B (en) | 2013-03-15 | 2017-06-30 | 微仙美国有限公司 | Embolization protective device |
EP2988793B1 (en) | 2013-04-22 | 2019-01-02 | Stryker European Holdings I, LLC | Method for drug loading hydroxyapatite coated implant surfaces |
US9445928B2 (en) | 2013-05-30 | 2016-09-20 | Medtronic Vascular, Inc. | Delivery system having a single handed deployment handle for a retractable outer sheath |
US9675782B2 (en) | 2013-10-10 | 2017-06-13 | Medtronic Vascular, Inc. | Catheter pull wire actuation mechanism |
US9795391B2 (en) | 2013-10-25 | 2017-10-24 | Medtronic Vascular, Inc. | Tissue compression device with tension limiting strap retainer |
US9808599B2 (en) | 2013-12-20 | 2017-11-07 | Microvention, Inc. | Device delivery system |
JP6412137B2 (en) | 2013-12-20 | 2018-10-24 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Discharge adapter |
ES2684405T3 (en) | 2014-04-08 | 2018-10-02 | Stryker Corporation | Implant delivery system |
US20170049596A1 (en) | 2014-04-30 | 2017-02-23 | Stryker Corporation | Implant delivery system and method of use |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
US9668898B2 (en) | 2014-07-24 | 2017-06-06 | Medtronic Vascular, Inc. | Stent delivery system having dynamic deployment and methods of manufacturing same |
US9770577B2 (en) | 2014-09-15 | 2017-09-26 | Medtronic Xomed, Inc. | Pressure relief for a catheter balloon device |
US9579484B2 (en) | 2014-09-19 | 2017-02-28 | Medtronic Vascular, Inc. | Sterile molded dispenser |
US10595875B2 (en) | 2014-12-31 | 2020-03-24 | Endostream Medical Ltd. | Device for restricting blood flow to aneurysms |
US9692557B2 (en) | 2015-02-04 | 2017-06-27 | Stryker European Holdings I, Llc | Apparatus and methods for administering treatment within a bodily duct of a patient |
CN112869920A (en) | 2015-02-25 | 2021-06-01 | 盖乐西医疗公司 | Systems and methods for treating aneurysms |
US10154905B2 (en) | 2015-08-07 | 2018-12-18 | Medtronic Vascular, Inc. | System and method for deflecting a delivery catheter |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
EP3334354B1 (en) | 2015-08-11 | 2021-03-03 | Terumo Corporation | System for implant delivery |
WO2017049312A1 (en) | 2015-09-18 | 2017-03-23 | Microvention, Inc. | Releasable delivery system |
CN108348323B (en) | 2015-09-18 | 2021-11-16 | 微仙美国有限公司 | Implant retention, detachment and delivery system |
EP4327786A3 (en) | 2015-09-18 | 2024-05-01 | Terumo Corporation | Pushable implant delivery system |
EP3349669B1 (en) | 2015-09-18 | 2020-10-21 | Terumo Corporation | Vessel prosthesis |
JP6591664B2 (en) | 2015-09-21 | 2019-10-16 | ストライカー コーポレイションStryker Corporation | Embolization removal device |
US10441404B2 (en) | 2015-09-21 | 2019-10-15 | Stryker Corporation | Embolectomy devices |
US10172632B2 (en) | 2015-09-22 | 2019-01-08 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a stabilization tube |
US20170100143A1 (en) | 2015-10-07 | 2017-04-13 | Stryker Corporation | Multiple barrel clot removal devices |
US10327791B2 (en) | 2015-10-07 | 2019-06-25 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon |
US10786302B2 (en) | 2015-10-09 | 2020-09-29 | Medtronic, Inc. | Method for closure and ablation of atrial appendage |
US10271873B2 (en) | 2015-10-26 | 2019-04-30 | Medtronic Vascular, Inc. | Sheathless guide catheter assembly |
WO2017087816A1 (en) | 2015-11-19 | 2017-05-26 | Penumbra, Inc. | Systems and methods for treatment of stroke |
US10631946B2 (en) | 2015-11-30 | 2020-04-28 | Penumbra, Inc. | System for endoscopic intracranial procedures |
US10369326B2 (en) | 2015-12-09 | 2019-08-06 | Medtronic Vascular, Inc. | Catheter with a lumen shaped as an identification symbol |
US10500046B2 (en) | 2015-12-14 | 2019-12-10 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
US10159568B2 (en) | 2015-12-14 | 2018-12-25 | Medtronic, Inc. | Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis |
CN108472043B (en) | 2015-12-30 | 2022-05-31 | 斯瑞克公司 | Embolization device and method of making same |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
US10070950B2 (en) | 2016-02-09 | 2018-09-11 | Medtronic Vascular, Inc. | Endoluminal prosthetic assemblies, and associated systems and methods for percutaneous repair of a vascular tissue defect |
BR112018016352A2 (en) | 2016-02-10 | 2018-12-18 | Microvention Inc | vascular occlusion devices |
KR20220098399A (en) | 2016-02-10 | 2022-07-12 | 마이크로벤션, 인코포레이티드 | Intravascular treatment site access |
US10188500B2 (en) | 2016-02-12 | 2019-01-29 | Medtronic Vascular, Inc. | Stent graft with external scaffolding and method |
EP3436124B1 (en) | 2016-03-31 | 2022-08-31 | Medtronic Vascular Inc. | Expandable introducer sheath having a steering mechanism |
US20170281331A1 (en) | 2016-03-31 | 2017-10-05 | Medtronic Vascular, Inc. | Endoluminal prosthetic devices having fluid-absorbable compositions for repair of a vascular tissue defect |
US10695542B2 (en) | 2016-04-04 | 2020-06-30 | Medtronic Vascular, Inc. | Drug coated balloon |
US10252024B2 (en) | 2016-04-05 | 2019-04-09 | Stryker Corporation | Medical devices and methods of manufacturing same |
US10441407B2 (en) | 2016-04-12 | 2019-10-15 | Medtronic Vascular, Inc. | Gutter filling stent-graft and method |
US9987122B2 (en) | 2016-04-13 | 2018-06-05 | Medtronic Vascular, Inc. | Iliac branch device and method |
US10010403B2 (en) | 2016-04-18 | 2018-07-03 | Medtronic Vascular, Inc. | Stent-graft prosthesis and method of manufacture |
US20170304097A1 (en) | 2016-04-21 | 2017-10-26 | Medtronic Vascular, Inc. | Stent-graft delivery system having an inner shaft component with a loading pad or covering on a distal segment thereof for stent retention |
JP6934935B2 (en) | 2016-04-25 | 2021-09-15 | ストライカー コーポレイションStryker Corporation | Inverted mechanical thrombectomy and intravascular use |
US10517711B2 (en) | 2016-04-25 | 2019-12-31 | Medtronic Vascular, Inc. | Dissection prosthesis system and method |
US10940294B2 (en) | 2016-04-25 | 2021-03-09 | Medtronic Vascular, Inc. | Balloon catheter including a drug delivery sheath |
ES2925057T3 (en) | 2016-04-25 | 2022-10-13 | Stryker Corp | Preloaded Inverter Tractor Thrombectomy Sets |
EP3590446B1 (en) | 2016-04-25 | 2021-01-06 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses |
US10406011B2 (en) | 2016-04-28 | 2019-09-10 | Medtronic Vascular, Inc. | Implantable medical device delivery system |
US10191615B2 (en) | 2016-04-28 | 2019-01-29 | Medtronic Navigation, Inc. | Method and apparatus for image-based navigation |
US11147952B2 (en) | 2016-04-28 | 2021-10-19 | Medtronic Vascular, Inc. | Drug coated inflatable balloon having a thermal dependent release layer |
US10292844B2 (en) | 2016-05-17 | 2019-05-21 | Medtronic Vascular, Inc. | Method for compressing a stented prosthesis |
US10786659B2 (en) | 2016-06-01 | 2020-09-29 | Microvention, Inc. | Reinforced balloon catheter |
ES2924974T3 (en) | 2016-06-03 | 2022-10-13 | Stryker Corp | Reversal Thrombectomy Apparatus |
US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
-
2018
- 2018-08-03 US US16/054,055 patent/US10905431B2/en active Active
-
2019
- 2019-08-01 IL IL268442A patent/IL268442A/en unknown
- 2019-08-01 CA CA3050932A patent/CA3050932A1/en not_active Abandoned
- 2019-08-02 TW TW108127535A patent/TW202027685A/en unknown
- 2019-08-02 CO CONC2019/0008501A patent/CO2019008501A1/en unknown
- 2019-08-02 MX MX2019009239A patent/MX2019009239A/en unknown
- 2019-08-02 BR BR102019016092-6A patent/BR102019016092A2/en not_active IP Right Cessation
- 2019-08-02 EP EP19189856.8A patent/EP3603540A1/en not_active Withdrawn
- 2019-08-02 JP JP2019142882A patent/JP7358109B2/en active Active
- 2019-08-02 AU AU2019210654A patent/AU2019210654A1/en not_active Abandoned
- 2019-08-02 RU RU2019124547A patent/RU2019124547A/en unknown
- 2019-08-05 KR KR1020190094944A patent/KR20200015429A/en unknown
- 2019-08-05 CN CN201910717300.4A patent/CN110786907A/en not_active Withdrawn
-
2020
- 2020-12-21 US US17/128,338 patent/US11547414B2/en active Active
-
2023
- 2023-01-05 US US18/093,460 patent/US20230149023A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10905431B2 (en) | 2021-02-02 |
CA3050932A1 (en) | 2020-02-03 |
US20210106338A1 (en) | 2021-04-15 |
CN110786907A (en) | 2020-02-14 |
US20200038031A1 (en) | 2020-02-06 |
KR20200015429A (en) | 2020-02-12 |
CO2019008501A1 (en) | 2021-02-08 |
US11547414B2 (en) | 2023-01-10 |
MX2019009239A (en) | 2020-02-04 |
TW202027685A (en) | 2020-08-01 |
JP7358109B2 (en) | 2023-10-10 |
IL268442A (en) | 2020-02-27 |
AU2019210654A1 (en) | 2020-02-20 |
EP3603540A1 (en) | 2020-02-05 |
JP2020018858A (en) | 2020-02-06 |
RU2019124547A (en) | 2021-02-02 |
BR102019016092A2 (en) | 2020-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11547414B2 (en) | Spiral delivery system for embolic braid | |
US11672540B2 (en) | Aneurysm device and delivery system | |
US11633191B2 (en) | Folded aneurysm treatment device and delivery method | |
JP7139346B2 (en) | Aneurysm device and delivery system | |
US11583288B2 (en) | Delivery of embolic braid | |
EP3501429A1 (en) | Aneurysm device and delivery system | |
US20210401439A1 (en) | Intrasaccular device positioning and deployment system | |
US11337706B2 (en) | Aneurysm treatment device | |
EP3906863A2 (en) | Double layer braid for occlusion of aneurysms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GOROCHOW, LACEY;REEL/FRAME:062282/0353 Effective date: 20180724 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |